KaryoSeq

What is KaryoSeq?

KaryoSeq is a genetic diagnostic tool that employs low-pass Whole Genome Sequencing (WGS) to identify chromosomal abnormalities, including aneuploidies and copy number variations (CNVs). By providing a detailed and comprehensive analysis of the entire genome, the KaryoSeq test can uncover both large and small genetic changes that traditional methods might miss. The high-resolution and precise nature of KaryoSeq makes it a valuable tool for diagnosing a wide range of genetic conditions, ensuring that patients receive accurate and timely information about their genetic health.
KaryoSeq HD is a cost-effective, comprehensive genome-wide test that uses low-pass whole-genome sequencing. It is well validated, with 100% concordance for variants >50KB, delivering high resolution and a higher diagnostic yield in detecting chromosomal abnormalities. Additionally, Karyotyping Reflex KaryoSeq analyses specimens using low‐pass whole genome sequencing, offering improved reliability over traditional karyotyping (2–5% failure) and is effective in both prenatal and postnatal settings. This integrated approach aids in identifying genetic conditions that may be missed by karyotyping alone.

Comprehensive Validation and Precise Clinical Insights

ParameterDetails
Validation Study
  • 10 normal samples.
  • 138 abnormal samples.
  • 112 additional samples.
  • Total sample types: AF, CVS, POC, fetal DNA, peripheral blood.
  • Aberrations identified
  • Whole chromosome aneuploidies.
  • Copy number variations (CNVs).
  • Concordance
  • KaryoSeq demonstrated 100% concordance for chromosomal abnormalities detected using its low-pass WGS methodology.
  • Clinical Indications of KaryoSeq Testing

    • Confirmation of suspected aneuploidies (T21, T18, T13, Monosomy X, etc.).
    • Suspected microdeletions or microduplications.
    • Pregnancy losses (POC testing).
    • Prenatal samples requiring high-resolution genome-wide analysis (AF, CVS).
    • Postnatal cases with developmental delays, congenital anomalies, or suspected genetic syndromes.
    • Cases where traditional karyotyping is inconclusive or fails.

    Specifications

    • Methodology: Low-pass whole genome sequencing (NGS).
    • Resolution: High-resolution detection of CNVs and whole-chromosome abnormalities.
    • Sample Types: Amniotic fluid (AF), chorionic villus sampling (CVS), product of conception (POC), direct fetal DNA, peripheral blood DNA.
    • Applications: Prenatal & Postnatal.
    • Diagnostic Yield: Higher than traditional cytogenetics.
    Human DNA structure highlighting MedGenome genetic testing and DNA test in India

    KaryoSeq Tests Offered by MedGenome

    Key Highlights of MedGenome's KaryoSeq Test

    Genome-Wide Analysis

    KaryoSeq uses Low-Pass Whole-Genome sequencing to cover all chromosomes with high accuracy.

    High Concordance

    KaryoSeq offers 100% validation for CNVs larger, ensuring precise and reliable detection of chromosomal abnormalities through advanced sequencing techniques.

    Versatile Applications

    KaryoSeq is suitable for prenatal testing with amniotic fluid and chorionic villus sampling (CVS) and postnatal testing using peripheral blood samples.

    What is KaryoSeq?

    KaryoSeq is an advanced genetic testing method developed by MedGenome Labs to analyse chromosomal abnormalities more accurately than traditional techniques. Unlike conventional karyotyping, which relies on the visual inspection of chromosomes under a microscope, the KaryoSeq test uses next-generation sequencing (NGS) technology. This allows for a detailed examination of chromosomes, identifying even the smallest changes. MedGenome's KaryoSeq HD enhances traditional KaryoSeq by offering higher resolution, enabling the detection of smaller chromosomal abnormalities. Additionally, the Karyotyping Reflex KaryoSeq uses reflex analysis (FISH-5 markers or G-Banding) and serves as an alternative when standard karyotyping cultures fail to grow, ensuring comprehensive chromosomal analysis.

    How Does the KaryoSeq Test Differ from Karyotyping?

    FeatureKaryotypingMedGenome’s KaryoSeq
    Detection of Small ChangesHighly effective for detecting large chromosomal changesDetects subtle chromosomal changes. KaryoSeq - >1Mb, KaryoSeq HD - 50Kb
    Genome CoverageLooks at whole chromosomes.Provides a comprehensive genome-wide analysis, capturing a broader spectrum of chromosomal issues.
    Turnaround Time2-3 weeks, as cell culture is required.Faster results in 10 - 12 working days
    Technological BasisVisual analysis under a microscope.NGS-based genomic sequencing.
    Diagnostic YieldEffective for detecting large chromosomal changes.Higher, including small CNVs
    Application ScopeBest for large aneuploidies and structural changes.Detects aneuploidies, CNVs, and fine abnormalities.
    MedGenome scientist conducting genetic testing and DNA test services in India

    What Types of Chromosomal Abnormalities Can KaryoSeq Detect?

    The KaryoSeq Test is designed to identify a wide range of chromosomal abnormalities, including:

    • Numerical Abnormalities: These include changes in the number of chromosomes, such as:
      • Trisomy: The presence of an extra chromosome, resulting in conditions like Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13).
      • Monosomy: The absence of one chromosome from the normal pair, such as Turner syndrome (Monosomy X), where a female has only one X chromosome instead of two.
    • Structural Abnormalities: These involve changes in the structure of chromosomes, such as:
      • Deletions: Missing segments of a chromosome, which can result in genetic disorders depending on the genes located in that segment.
      • Duplications: Extra segments of a chromosome which can disrupt normal gene function and lead to genetic conditions.
    • Microdeletions and Microduplications: These are tiny segments of chromosomes that are either missing (microdeletions) or duplicated (microduplications), which are often missed by traditional methods:
      • Microdeletions: Small deletions that can lead to conditions like Prader-Willi syndrome, Angelman syndrome, and DiGeorge syndrome.
      • Microduplications: Small duplications that can cause various genetic disorders.

    This comprehensive detection capability makes KaryoSeq a powerful tool for diagnosing various genetic conditions.

    MedGenome clinician reviewing patient records to support genetic testing and DNA test in India

    What Are the Advantages of Using KaryoSeq for Prenatal Genetic Testing?

    KaryoSeq offers several benefits when used in prenatal genetic testing:

    • Higher Detection Accuracy: It provides detailed insights into chromosomal abnormalities that traditional methods might overlook.
    • Faster Turnaround Time: Results are available quicker compared to conventional karyotyping, enabling timely medical decisions.
    • Early Diagnosis: Detects various genetic disorders, allowing for better preparation and management during pregnancy.
    • Comprehensive Analysis: Offers a more in-depth understanding of chromosomal health, ensuring no critical detail is missed.
    • Cost-Effective: Provides comprehensive genomic analysis at a reasonable cost.
    • Validated: Ensures accurate results with 100% concordance for CNVs greater than 1 Mb.
    • Versatile: Suitable for both prenatal (amniotic fluid, chorionic villus sampling, products of conception) and postnatal (peripheral blood DNA) samples.

    Frequently Asked Questions (FAQs)

    • How much does the KaryoSeq test cost in India?

      The cost of KaryoSeq testing in India varies based on the type of sample and the specific genetic analysis required. It’s best to contact MedGenome or a partnered healthcare provider for exact pricing. Generally, KaryoSeq is competitively priced compared to other advanced genetic tests, considering its comprehensive analysis capabilities.

    • What sample is used for KaryoSeq testing?

      KaryoSeq testing can be performed on various sample types depending on the clinical need, such as:

      • Blood: Commonly used for postnatal testing.
      • Amniotic Fluid: Used for prenatal testing during the second trimester.
      • Chorionic Villus Sampling (CVS): Collected during the first trimester for early prenatal genetic testing.
      • Tissue Samples: In specific cases like miscarriage analysis.
      The choice of sample type will depend on the patient's condition and the healthcare provider's recommendation.

    • How long does it take to get results from KaryoSeq testing?

      KaryoSeq testing typically delivers results within 10 - 12 working days. However, the exact duration may vary depending on the sample type and the complexity of the analysis. This relatively quick turnaround time helps in making prompt and informed medical decisions.

    Get Genetic Counselling by Our Experts

    Connect with Our Experts

      MedGenome Patient Stories

      MedGenome in the News

      September 12, 2023 5 mins read

      NIPT for Twins: What You Should Know?

      December 30, 2021 5 mins read

      Unlocking Insights: Genetic Tests Every Woman Should Consider

      August 21, 2019 5 mins read

      A new technology for eradicating TB – MedGenome Labs – Mathrubhumi

      Please share your details to get
      in touch with our experts.